Tag | Content |
---|
EnhancerAtlas ID | HS130-16404 |
Organism | Homo sapiens |
Tissue/cell | MDA-MB-231 |
Coordinate | chr21:39616030-39618120 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr21:39617621-39617639 | GAAAGGAAAGAAAGAAAG | + | 6.03 | EWSR1-FLI1 | MA0149.1 | chr21:39617516-39617534 | GAAAGAAAGAAAGGAGGG | + | 6.09 | EWSR1-FLI1 | MA0149.1 | chr21:39617543-39617561 | GAGAGGAAGGAAGGGAAG | + | 6.25 | EWSR1-FLI1 | MA0149.1 | chr21:39617650-39617668 | GAAAGGAAGGAAGGAGAA | + | 6.46 | EWSR1-FLI1 | MA0149.1 | chr21:39617520-39617538 | GAAAGAAAGGAGGGAAGG | + | 6.98 | EWSR1-FLI1 | MA0149.1 | chr21:39617528-39617546 | GGAGGGAAGGAAGGAGAG | + | 7.58 | EWSR1-FLI1 | MA0149.1 | chr21:39617524-39617542 | GAAAGGAGGGAAGGAAGG | + | 8.69 | GLI2 | MA0734.2 | chr21:39617787-39617802 | AGACCACCCACAAAG | + | 7.02 | GLIS3 | MA0737.1 | chr21:39617788-39617802 | GACCACCCACAAAG | + | 6.26 | HNF1A | MA0046.2 | chr21:39618019-39618034 | AATTAATAATTAAAT | + | 6.58 | IRF1 | MA0050.2 | chr21:39617639-39617660 | AGAGAGAAAGAGAAAGGAAGG | - | 6.44 | ZNF263 | MA0528.1 | chr21:39617544-39617565 | AGAGGAAGGAAGGGAAGGGAA | + | 6.25 | ZNF263 | MA0528.1 | chr21:39617545-39617566 | GAGGAAGGAAGGGAAGGGAAA | + | 6.2 | ZNF263 | MA0528.1 | chr21:39617659-39617680 | GAAGGAGAAAGAGAATGAAAG | + | 6.36 | ZNF263 | MA0528.1 | chr21:39617537-39617558 | GAAGGAGAGAGGAAGGAAGGG | + | 6.45 | ZNF263 | MA0528.1 | chr21:39617533-39617554 | GAAGGAAGGAGAGAGGAAGGA | + | 6.94 | ZNF263 | MA0528.1 | chr21:39617525-39617546 | AAAGGAGGGAAGGAAGGAGAG | + | 6.99 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_09241 | chr21:39616014-39619090 | CD14 | SE_45623 | chr21:39615784-39618542 | Osteoblasts | SE_51700 | chr21:39615831-39618527 | Skeletal_Muscle_Myoblast | SE_55658 | chr21:39611717-39618807 | u87 | SE_63489 | chr21:39615519-39618707 | HSMM | SE_67472 | chr21:39611717-39618807 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 39616081 | 39616344 | chr21 | 39616792 | 39617335 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I038244 | chr21 | 39615930 | 39618220 |
|
Enhancer Sequence | TCTCCTATTA ATTTTTTTTT TGTCTTTGTG ACTATCTTGT TTATACAAAC TGAACCTGAG 60 ACAAAGCCGC TAGTGACTGC TTTTTGTGGT TAAACTGGTT TCGAACCCAC CAAAGTCTAG 120 AAGAGGGAAA GAAAGAATTG TACCAGATTT GATGTGTTTT GTGTAACGTA AGCCAGATTG 180 TACCTCCTTC TCTCTCTCCC AGGTCTGTAT ACAACTTAGG ACCAAGAGGT GGACTTTGGT 240 GTCTTAGTTC AAGCTCTAAA AATACCAGGG AAGCAGGGAC CACGACACAT CCCAGGCTTG 300 GTGCAGAAAC CTGACCTGAA TTGGACCTTA AGATCAGAAT ATAGATCTAT TGTCTTTCCT 360 CACCTGGCTG TTACCAAACT AACTTCCGCA TCTCCTGGGA GTGCTTTCTA TTTCATCCAG 420 GCAGTGCCCT TATCTGATCT GGAGTGGGTT TATCTCTGGG AGAGCTATTG AAGTGCCTGA 480 CAGGAGAGGA CACTAAGAGT ACCTCCAGTC TCCAACTGCC TCCTCCGGCA GAACTGAGCA 540 AGTCCTAACC ATGCCAAAAA CATCATTATC TCTGGTTCCA TCTTAGTCCC TGCACACCCT 600 AGGATTCAAG GACTCAAGTA AGTTGGGGAG GGGAACATCT TTTCACCCCT GGAAAACCTT 660 GTCTCCTCCC AAGCCCTGGG AGGGGAGAAC TGCTGCTAAT GAGATGCTGG TAGTTAGTCT 720 TGTAATTTTT ACAGTATTAT CTGCAGAATG AATGACTACC AGCAGGTACT CTGAATCTCT 780 TTTCTTTCTA ATAAGATGTA ATCAACGAAC CAGATTGTGG CCTTGGAGCT GACCAAAGGA 840 TCAGCTAAAG GAATTGGACA CATCCTGAGC TAGTTAACAC ATGGGTATTG TCGGTCTAAG 900 ATGCTCTTTA GGGGCTAGTG ACTCATTCAT GATGTGCAGG AAATGGCACA GACACCTCCA 960 TGACCACAGA AGGTTTCTAC AGGCGCCGTC ATCACAGGGT CTACAAACAG AAGGAAGTCA 1020 GAGAGAGAGG CTCAGGGGAA GGCAAGGCGG GGCTGGAGAC CTGGATTCTA CGTCGGAGTT 1080 TACCGCATCC TGGTTCTATT CCCAAAGTCC TCTCTGTGTG GCCATATGCC TGATTCTCAG 1140 CCTGGCTTCA TTCCAGTCAT CTCAGGATCT TACAAACAAC ATTGATGTCC AGGCCCCACC 1200 CCAGACCAAT GAAATCAGAA TCTCTTGGAC ATTAAAAAAA AAAATGAGTG ATTCTTTCTG 1260 GGTGATTCTA ATATGTGGTC AGGGTTGAGG CCACTGCTTT ACTTCATTAC ATCATGACAC 1320 TAAAAATACT ACTGGAAAGA AAAAAGGAGG GCTACCATCT GCCTTCCAAT CTCTTCAGCT 1380 GGGAACCTCT TCATAAGACT GTATCTGAAA CCAGGATACG AGATCCTTAT AAGTAATTCC 1440 ATTTATAATA ACAAAGAAAG AAAAGAAAGA AAGAAAGAGA GAGAGAGAAA GAAAGAAAGG 1500 AGGGAAGGAA GGAGAGAGGA AGGAAGGGAA GGGAAAGAGA GACAGAGAAA GGAAAGAAGA 1560 AAGAAAGAAG GAAAGGGAAG AAAGAAAGAA GGAAAGGAAA GAAAGAAAGA GAGAGAAAGA 1620 GAAAGGAAGG AAGGAGAAAG AGAATGAAAG GTGTTTACAG CTGGAAATCA AACAGAACTT 1680 TGCCTGACAC ATGTTCATTT TTGGCCATTT TTGCCTTTTT TGTGGTGTGA ACCATTAGTT 1740 CAGCCCAGTT AACCCTGAGA CCACCCACAA AGACTGAATT CAGAGGTGGC TGTCCAGTAC 1800 AGTGATTCAA GGTGAGGCCT GTGAAGTGAG ATCAAGATTT GAATTTCTGC TTCTCAGTTC 1860 ACCAACTATT TGACCTTGGG CAAGTGACTT AATTCAAGAC TTAGTTTTAT CATTTATAAA 1920 GTAAGAAGAA TAATACCTGT CTTACATACT CTGATTTGTT GATATGATAG TCAATATGCT 1980 ATAAGAATAA ATTAATAATT AAATGACACG GTAGACATAA GGCATTTAAA TCTAATTCCT 2040 GATCCACAGC AAACCTTCAA CAAATAGCAG CTGTTATCAT CAGAGCTAAA 2090
|